US earmarks up to $680M for Chimerix’s smallpox drug Tembexa, clearing way for Emergent buyout

During the latest monkeypox outbreak, doctors in the U.S. have been treating patients with Siga Technologies’ smallpox drug Tpoxx. Now, the U.S. government may have a second potential antiviral option at its disposal.